Design, Synthesis, Molecular Modeling, Biological Activity, and Mechanism of Action of Novel Amino Acid Derivatives of Norfloxacin
ACS Omega · 14.11.2023 · 8 (45) · 43271-43284
DOI: 10.1021/acsomega.3c07221 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 01.11.2023. Verfasst von Ahmed M Kamal El-Sagheir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Department, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chalmers Tekniska Högskola.
Abstract (Originalsprache)
Two series of N4-substituted piperazinyl amino acid derivatives of norfloxacin (24 new compounds) were designed and synthesized to attain structural surrogates with additional binding sites and enhanced antibacterial activity. Synthesized derivatives showed increased antibacterial and antimycobacterial activity compared to their lead structure, norfloxacin. Molecular modeling studies supported the notion that the derivatives can establish additional bonds with the target enzymes gyrase and topoisomerase IV. In vitro enzyme inhibition assays confirmed that the tested compounds were significant inhibitors of these enzymes. Inhibition of gyrase and topoisomerase IV was then confirmed in living bacterial cells using bacterial cytological profiling of both Gram-negative Escherichia coli and Gram-positive Bacillus subtilis, revealing a typical topoisomerase inhibition phenotype characterized by severe nucleoid packing defects. Several derivatives exhibited additional effects on the Gram-positive cell wall synthesis machinery and/or the cytoplasmic membrane, which likely contributed to their increased antibacterial activity. While we could not identify specific cell wall or membrane targets, membrane depolarization was not observed. Our experiments further suggest that cell wall synthesis inhibition most likely occurs outside the membrane-bound lipid II cycle.
Autor:innen und Institutionen
- Medicinal Chemistry Department, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.
- Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden.
- Center for Antibiotic Resistance Research in Gothenburg (CARe), Gothenburg 405 30, Sweden.
ORCID-Profile: Mohammed K Abd El-Gaber, Ahmed S Aboraia, Michaela Wenzel
Förderung
- Chalmers Tekniska Högskola
Zitieren
APA
Kamal El-Sagheir, A. M., Abdelmesseh Nekhala, I., Abd El-Gaber, M. K., Aboraia, A. S., Persson, J., Schäfer, A. B., Wenzel, M., & Omar, F. A. (2023). Design, Synthesis, Molecular Modeling, Biological Activity, and Mechanism of Action of Novel Amino Acid Derivatives of Norfloxacin. ACS Omega, 8(45), 43271-43284. https://doi.org/10.1021/acsomega.3c07221
Vancouver
Kamal El-Sagheir AM, Abdelmesseh Nekhala I, Abd El-Gaber MK, Aboraia AS, Persson J, Schäfer AB, et al. Design, Synthesis, Molecular Modeling, Biological Activity, and Mechanism of Action of Novel Amino Acid Derivatives of Norfloxacin. ACS Omega. 2023;8(45):43271-43284. doi:10.1021/acsomega.3c07221
BibTeX
@article{KamalElSagheir2023,
author = {Kamal El-Sagheir, Ahmed M and Abdelmesseh Nekhala, Ireny and Abd El-Gaber, Mohammed K and Aboraia, Ahmed S and Persson, Jonatan and Schäfer, Ann-Britt and Wenzel, Michaela and Omar, Farghaly A},
title = {Design, Synthesis, Molecular Modeling, Biological Activity, and Mechanism of Action of Novel Amino Acid Derivatives of Norfloxacin},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {45},
pages = {43271--43284},
doi = {10.1021/acsomega.3c07221}
}
EUVIMED